Pfizer tops Q1 expectations, revises 2022 forecast
Sales of Pfizers COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%. The coronavirus...
Sales of Pfizers COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%. The coronavirus...